eResearch Technology (ERT +16.9%) shares soar after Q4 results beat analyst estimates and Benchmark says it believes underlying clinical research industry trends recovered late in 2011 and have now returned to a favorable track. In raising shares to Buy, the firm expects improved margins, profitability and cash flow with the recent release of the Expert3 platform.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs